{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T18:33:53Z","timestamp":1793385233040,"version":"4.5.0"},"reference-count":116,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2017,11,24]],"date-time":"2017-11-24T00:00:00Z","timestamp":1511481600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["2K12 CA132783\u201006"],"award-info":[{"award-number":["2K12 CA132783\u201006"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Head &amp; Neck"],"published-print":{"date-parts":[[2018,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>This article is a continuation of the \u201cDo You Know Your Guidelines\u201d series, initiated by the Education committee of the American Head and Neck Society. Treatment guidelines for advanced head and neck squamous cell carcinoma are reviewed here, including the critical roles of radiotherapy, chemotherapy, and the recent application of immunotherapy agents. We will be limiting this discussion to include cancers of the oral cavity, oropharynx, hypopharynx, and larynx. It should be noted that much of the article pertains to human papillomavirus (HPV)\u2010negative oropharyngeal cancer where applicable, as HPV\u2010positive oropharyngeal squamous cell carcinoma carries a different natural history, different prognosis, and now different staging criteria. Additionally, the article will not include information on nasopharyngeal or sinus cancers, as these latter topics are covered in separate \u201cDo you know your guidelines?\u201d installments and these diagnoses carry somewhat different approaches to diagnosis and management that diverge from the focus of this article.<\/jats:p>","DOI":"10.1002\/hed.25025","type":"journal-article","created":{"date-parts":[[2017,11,24]],"date-time":"2017-11-24T13:42:44Z","timestamp":1511530964000},"page":"676-686","source":"Crossref","is-referenced-by-count":30,"title":["AHNS Series: Do you know your guidelines? Principles of treatment for locally advanced or unresectable head and neck squamous cell carcinoma"],"prefix":"10.1002","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7259-9807","authenticated-orcid":false,"given":"Cory D.","family":"Fulcher","sequence":"first","affiliation":[{"name":"Montefiore Medical Center\/Albert Einstein College of Medicine Bronx New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"Missak","family":"Haigentz","sequence":"additional","affiliation":[{"name":"Department of Medicine (Oncology) Albert Einstein College of Medicine Bronx New York"},{"name":"Department of Otorhinolaryngology\u2010Head and Neck Surgery Albert Einstein College of Medicine Bronx New York"},{"name":"Department of Medicine (Oncology) Morristown Medical Center\/Atlantic Health System Morristown New Jersey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas J.","family":"Ow","sequence":"additional","affiliation":[{"name":"Department of Otorhinolaryngology \u2010 Head and Neck Surgery and Department of Pathology Montefiore Medical Center\/Albert Einstein College of Medicine Bronx New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"The Education Committee of the American Head and Neck Society (AHNS)","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2017,11,24]]},"reference":[{"key":"e_1_2_4_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)60728-X"},{"key":"e_1_2_4_3_1","unstructured":"National Comprehensive Cancer Network.Head and Neck Cancers Version 2.2017.https:\/\/www.nccn.org\/professionals\/physician_gls\/PDF\/head\u2010and\u2010neck.pdf."},{"key":"e_1_2_4_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(10)70017-6"},{"key":"e_1_2_4_5_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.55.3925"},{"key":"e_1_2_4_6_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdr006"},{"key":"e_1_2_4_7_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.29.2904"},{"key":"e_1_2_4_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(15)00560-4"},{"key":"e_1_2_4_9_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-40618-3_10"},{"key":"e_1_2_4_10_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-40618-3_11"},{"key":"e_1_2_4_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/0360-3016(85)90180-4"},{"key":"e_1_2_4_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0360-3016(96)00614-1"},{"key":"e_1_2_4_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9610(85)90162-X"},{"key":"e_1_2_4_14_1","doi-asserted-by":"publisher","DOI":"10.1001\/archotol.1994.01880360066012"},{"key":"e_1_2_4_15_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.21340"},{"key":"e_1_2_4_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2273.1979.tb01900.x"},{"key":"e_1_2_4_17_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12105-010-0161-y"},{"key":"e_1_2_4_18_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa032641"},{"key":"e_1_2_4_19_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa032646"},{"key":"e_1_2_4_20_1","doi-asserted-by":"publisher","DOI":"10.1002\/hed.20279"},{"key":"e_1_2_4_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2012.05.008"},{"key":"e_1_2_4_22_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-0-387-88441-7"},{"key":"e_1_2_4_23_1","first-page":"77","article-title":"Cetuximab: its unique place in head and neck cancer treatment","volume":"7","author":"Specenier P","year":"2013","journal-title":"Biologics."},{"issue":"15","key":"e_1_2_4_24_1","first-page":"3579","article-title":"Elevated levels of transforming growth factor alpha and epidermal growth factor receptor messenger RNA are early markers of carcinogenesis in head and neck cancer","volume":"53","author":"Grandis JR","year":"1993","journal-title":"Cancer Res."},{"issue":"24","key":"e_1_2_4_25_1","first-page":"7350","article-title":"Impact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinoma","volume":"62","author":"Ang KK","year":"2002","journal-title":"Cancer Res."},{"key":"e_1_2_4_26_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/90.11.824"},{"key":"e_1_2_4_27_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.07.2587"},{"key":"e_1_2_4_28_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.06.6605"},{"key":"e_1_2_4_29_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.53.9163"},{"key":"e_1_2_4_30_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa053422"},{"key":"e_1_2_4_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(09)70311-0"},{"key":"e_1_2_4_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2011.02.062"},{"key":"e_1_2_4_33_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.25374"},{"issue":"5","key":"e_1_2_4_34_1","first-page":"1580","article-title":"Prognostic significance of p16 in locoregionally advanced head and neck cancer treated with concurrent 5\u2010fluorouracil, hydroxyurea, cetuximab and intensity\u2010modulated radiation therapy","volume":"27","author":"Tong CC","year":"2012","journal-title":"Oncol Rep."},{"key":"e_1_2_4_35_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdq412"},{"key":"e_1_2_4_36_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.53.5633"},{"key":"e_1_2_4_37_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2004.08.021"},{"key":"e_1_2_4_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(11)70346-1"},{"key":"e_1_2_4_39_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2004.12.012"},{"key":"e_1_2_4_40_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1994.12.2.385"},{"key":"e_1_2_4_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0360-3016(00)00408-9"},{"key":"e_1_2_4_42_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1994.12.12.2648"},{"key":"e_1_2_4_43_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/88.9.583"},{"key":"e_1_2_4_44_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199806183382503"},{"key":"e_1_2_4_45_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1998.16.4.1318"},{"key":"e_1_2_4_46_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2000.18.7.1458"},{"key":"e_1_2_4_47_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.01.008"},{"key":"e_1_2_4_48_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1995.17"},{"key":"e_1_2_4_49_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1996.14.3.838"},{"key":"e_1_2_4_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)90011-4"},{"key":"e_1_2_4_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2007.04.088"},{"key":"e_1_2_4_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2009.04.014"},{"issue":"6","key":"e_1_2_4_53_1","first-page":"328","article-title":"Meta\u2010analysis of chemotherapy in head and neck cancer (MACH\u2010NC): an update on 100 randomized trials and 19,248 patients, on behalf of MACH\u2010NC group","volume":"27","author":"Bourhis J","year":"2016","journal-title":"Ann Oncol."},{"key":"e_1_2_4_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2012.08.009"},{"key":"e_1_2_4_55_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199106133242402"},{"key":"e_1_2_4_56_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/88.13.890"},{"key":"e_1_2_4_57_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa031317"},{"key":"e_1_2_4_58_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.43.6097"},{"key":"e_1_2_4_59_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2004.00.1990"},{"key":"e_1_2_4_60_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa070956"},{"key":"e_1_2_4_61_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa071028"},{"key":"e_1_2_4_62_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djp007"},{"key":"e_1_2_4_63_1","doi-asserted-by":"crossref","DOI":"10.1200\/jco.2009.27.15_suppl.6009","article-title":"Final results of a randomized phase III trial comparing induction chemotherapy with cisplatin\/5\u2010FU or docetaxel\/cisplatin\/5\u2010FU follow by chemoradiotherapy (CRT) versus CRT alone as first\u2010line treatment of unresectable locally advanced head and neck cancer (LAHNC)","volume":"27","author":"Hitt R","year":"2009","journal-title":"J Clin Oncol."},{"key":"e_1_2_4_64_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(13)70011-1"},{"key":"e_1_2_4_65_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.54.6309"},{"key":"e_1_2_4_66_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdt461"},{"key":"e_1_2_4_67_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.42.3988"},{"key":"e_1_2_4_68_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdp573"},{"key":"e_1_2_4_69_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2009.04.066"},{"key":"e_1_2_4_70_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0802656"},{"key":"e_1_2_4_71_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.07.120"},{"key":"e_1_2_4_72_1","doi-asserted-by":"publisher","DOI":"10.1080\/07357900701209061"},{"key":"e_1_2_4_73_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.01.057"},{"key":"e_1_2_4_74_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.02.4646"},{"key":"e_1_2_4_75_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1992.10.8.1245"},{"key":"e_1_2_4_76_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1992.10.2.257"},{"key":"e_1_2_4_77_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdq453"},{"key":"e_1_2_4_78_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdr367"},{"issue":"18","key":"e_1_2_4_79_1","article-title":"Experience with cetuximab plus paclitaxel\/carboplatinum in primary platinum\u2010resistant recurrent head and neck cancer","volume":"25","author":"Buentzel J","year":"2007","journal-title":"J Clin Oncol."},{"issue":"7","key":"e_1_2_4_80_1","first-page":"723","article-title":"Platinum analogs in recurrent and advanced head and neck cancer: a Southwest Oncology Group and Wayne State University study","volume":"71","author":"Al\u2010Sarraf M","year":"1987","journal-title":"Cancer Treat Rep."},{"key":"e_1_2_4_81_1","doi-asserted-by":"publisher","DOI":"10.3109\/00016480802590451"},{"key":"e_1_2_4_82_1","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.annonc.a058908"},{"key":"e_1_2_4_83_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2004.05.019"},{"key":"e_1_2_4_84_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.17.0530"},{"key":"e_1_2_4_85_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.06.7447"},{"key":"e_1_2_4_86_1","doi-asserted-by":"publisher","DOI":"10.1080\/14656566.2016.1183647"},{"key":"e_1_2_4_87_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(15)70124-5"},{"key":"e_1_2_4_88_1","doi-asserted-by":"publisher","DOI":"10.1080\/13543784.2016.1181747"},{"key":"e_1_2_4_89_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6605697"},{"key":"e_1_2_4_90_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2012.03.019"},{"key":"e_1_2_4_91_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005537-200003001-00001"},{"key":"e_1_2_4_92_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2017.01.008"},{"key":"e_1_2_4_93_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.24595"},{"key":"e_1_2_4_94_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.15.0102"},{"key":"e_1_2_4_95_1","doi-asserted-by":"publisher","DOI":"10.4065\/83.4.489"},{"key":"e_1_2_4_96_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11912-010-0147-7"},{"key":"e_1_2_4_97_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.20536"},{"key":"e_1_2_4_98_1","doi-asserted-by":"publisher","DOI":"10.1002\/hed.10314"},{"key":"e_1_2_4_99_1","doi-asserted-by":"publisher","DOI":"10.1002\/lary.20576"},{"key":"e_1_2_4_100_1","doi-asserted-by":"publisher","DOI":"10.1001\/archotol.125.4.379"},{"key":"e_1_2_4_101_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1514493"},{"key":"e_1_2_4_102_1","doi-asserted-by":"publisher","DOI":"10.1002\/hed.24100"},{"key":"e_1_2_4_103_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-12-2982"},{"key":"e_1_2_4_104_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-014-1457-7"},{"key":"e_1_2_4_105_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2011.12.009"},{"key":"e_1_2_4_106_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-12-2384"},{"issue":"19","key":"e_1_2_4_107_1","first-page":"6501","article-title":"B7\u2010H1 blockade augments adoptive T\u2010cell immunotherapy for squamous cell carcinoma","volume":"63","author":"Strome SE","year":"2003","journal-title":"Cancer Res."},{"key":"e_1_2_4_108_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12105-012-0406-z"},{"key":"e_1_2_4_109_1","doi-asserted-by":"publisher","DOI":"10.1038\/srep43627"},{"key":"e_1_2_4_110_1","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2010.130"},{"key":"e_1_2_4_111_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2011.08.007"},{"key":"e_1_2_4_112_1","unstructured":"U.S. Food and Drug Administration.Pembrolizumab (KEYTRUDA). 9 August2016.www.fda.gov. Accessed July 7 2017."},{"key":"e_1_2_4_113_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(16)30066-3"},{"key":"e_1_2_4_114_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.68.1478"},{"key":"e_1_2_4_115_1","unstructured":"U.S. Food and Drug Administration.Nivolumab for SCCHN. 10 November2016.www.fda.gov. Accessed July 7 2017."},{"key":"e_1_2_4_116_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1602252"},{"key":"e_1_2_4_117_1","unstructured":"Merck & Co. Inc.(2017).Merck Provides Update on Phase 3 Study of KEYTRUDA\u00ae (pembrolizumab) Monotherapy in Patients with Previously Treated Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC). [Press release].http:\/\/investors.merck.com\/news\/press\u2010release\u2010details\/2017\/Merck\u2010Provides\u2010Update\u2010on\u2010Phase\u20103\u2010Study\u2010of\u2010KEYTRUDA\u2010pembrolizumab\u2010Monotherapy\u2010in\u2010Patients\u2010with\u2010Previously\u2010Treated\u2010Recurrent\u2010or\u2010Metastatic\u2010Head\u2010and\u2010Neck\u2010Squamous\u2010Cell\u2010Carcinoma\u2010HNSCC\/default.aspx. Accessed July 7 2017."}],"container-title":["Head &amp; Neck"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhed.25025","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/hed.25025","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T15:05:54Z","timestamp":1695654354000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/hed.25025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,24]]},"references-count":116,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["10.1002\/hed.25025"],"URL":"https:\/\/doi.org\/10.1002\/hed.25025","archive":["Portico"],"relation":{},"ISSN":["1043-3074","1097-0347"],"issn-type":[{"value":"1043-3074","type":"print"},{"value":"1097-0347","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,24]]}}}